Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE28.2350
- TODAY'S CHANGE (%)-0.0550 (-0.1944%)
- Bid / Lots28.2300/ 3
- Ask / Lots28.2400/ 3
- Open / Previous Close28.3200 / 28.2900
- Day Range
- 52 Week Range
- Volume688,534
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 11199 | 28.33 |
| 09:34 ET | 3066 | 28.27 |
| 09:36 ET | 1508 | 28.27 |
| 09:38 ET | 1200 | 28.2 |
| 09:39 ET | 2168 | 28.2157 |
| 09:41 ET | 1124 | 28.225 |
| 09:43 ET | 5222 | 28.26 |
| 09:45 ET | 3960 | 28.28 |
| 09:48 ET | 7947 | 28.205 |
| 09:50 ET | 3970 | 28.26 |
| 09:52 ET | 10674 | 28.265 |
| 09:54 ET | 2887 | 28.265 |
| 09:56 ET | 1927 | 28.28 |
| 09:57 ET | 1400 | 28.295 |
| 09:59 ET | 2349 | 28.3 |
| 10:01 ET | 5075 | 28.34 |
| 10:03 ET | 1551 | 28.37 |
| 10:06 ET | 896 | 28.34 |
| 10:08 ET | 1461 | 28.315 |
| 10:10 ET | 1500 | 28.295 |
| 10:12 ET | 3051 | 28.27 |
| 10:14 ET | 11034 | 28.29 |
| 10:15 ET | 2591 | 28.285 |
| 10:17 ET | 3186 | 28.29 |
| 10:19 ET | 3565 | 28.235 |
| 10:21 ET | 10260 | 28.265 |
| 10:24 ET | 601 | 28.305 |
| 10:26 ET | 973 | 28.31 |
| 10:28 ET | 3399 | 28.295 |
| 10:30 ET | 4638 | 28.295 |
| 10:32 ET | 1014 | 28.315 |
| 10:33 ET | 1634 | 28.315 |
| 10:35 ET | 9172 | 28.375 |
| 10:37 ET | 2685 | 28.409 |
| 10:39 ET | 3925 | 28.43 |
| 10:42 ET | 1461 | 28.425 |
| 10:44 ET | 1793 | 28.41 |
| 10:46 ET | 2085 | 28.39 |
| 10:48 ET | 3327 | 28.38 |
| 10:50 ET | 3150 | 28.355 |
| 10:51 ET | 444 | 28.355 |
| 10:53 ET | 5926 | 28.365 |
| 10:55 ET | 1943 | 28.37 |
| 10:57 ET | 1148 | 28.37 |
| 11:00 ET | 915 | 28.375 |
| 11:02 ET | 1817 | 28.385 |
| 11:04 ET | 897 | 28.385 |
| 11:06 ET | 615 | 28.395 |
| 11:08 ET | 6225 | 28.385 |
| 11:09 ET | 812 | 28.385 |
| 11:11 ET | 2591 | 28.375 |
| 11:13 ET | 1384 | 28.38 |
| 11:15 ET | 12578 | 28.3709 |
| 11:18 ET | 13514 | 28.395 |
| 11:20 ET | 2116 | 28.405 |
| 11:22 ET | 4390 | 28.385 |
| 11:24 ET | 3502 | 28.38 |
| 11:26 ET | 1078 | 28.385 |
| 11:27 ET | 7074 | 28.385 |
| 11:29 ET | 32831 | 28.5269 |
| 11:31 ET | 7253 | 28.515 |
| 11:33 ET | 664 | 28.5103 |
| 11:36 ET | 2001 | 28.54 |
| 11:38 ET | 7293 | 28.48 |
| 11:40 ET | 9174 | 28.455 |
| 11:42 ET | 5859 | 28.475 |
| 11:44 ET | 8127 | 28.495 |
| 11:45 ET | 2080 | 28.485 |
| 11:47 ET | 5014 | 28.495 |
| 11:49 ET | 4454 | 28.465 |
| 11:51 ET | 2968 | 28.495 |
| 11:54 ET | 2943 | 28.485 |
| 11:56 ET | 2776 | 28.495 |
| 11:58 ET | 1831 | 28.4901 |
| 12:00 ET | 18730 | 28.505 |
| 12:02 ET | 3278 | 28.495 |
| 12:03 ET | 3849 | 28.525 |
| 12:05 ET | 2268 | 28.535 |
| 12:07 ET | 476 | 28.545 |
| 12:09 ET | 4745 | 28.535 |
| 12:12 ET | 4922 | 28.505 |
| 12:14 ET | 6847 | 28.48 |
| 12:16 ET | 3234 | 28.445 |
| 12:18 ET | 4110 | 28.44 |
| 12:20 ET | 2873 | 28.42 |
| 12:21 ET | 1520 | 28.435 |
| 12:23 ET | 1280 | 28.43 |
| 12:25 ET | 1508 | 28.4 |
| 12:27 ET | 3984 | 28.39 |
| 12:30 ET | 2102 | 28.385 |
| 12:32 ET | 3150 | 28.385 |
| 12:34 ET | 3497 | 28.37 |
| 12:36 ET | 1468 | 28.365 |
| 12:38 ET | 1508 | 28.365 |
| 12:39 ET | 489 | 28.355 |
| 12:41 ET | 3394 | 28.345 |
| 12:43 ET | 1743 | 28.325 |
| 12:45 ET | 1202 | 28.325 |
| 12:48 ET | 1295 | 28.315 |
| 12:50 ET | 5221 | 28.305 |
| 12:52 ET | 7911 | 28.315 |
| 12:54 ET | 1542 | 28.335 |
| 12:56 ET | 2113 | 28.3575 |
| 12:57 ET | 3407 | 28.34 |
| 12:59 ET | 2204 | 28.34 |
| 01:01 ET | 2660 | 28.33 |
| 01:03 ET | 3555 | 28.345 |
| 01:06 ET | 2531 | 28.335 |
| 01:08 ET | 2500 | 28.3 |
| 01:10 ET | 2558 | 28.305 |
| 01:12 ET | 4432 | 28.285 |
| 01:14 ET | 369 | 28.285 |
| 01:15 ET | 1314 | 28.285 |
| 01:17 ET | 7827 | 28.22 |
| 01:19 ET | 3403 | 28.235 |
| 01:21 ET | 1595 | 28.235 |
| 01:24 ET | 2518 | 28.225 |
| 01:26 ET | 6045 | 28.205 |
| 01:28 ET | 2002 | 28.2 |
| 01:30 ET | 1231 | 28.205 |
| 01:32 ET | 826 | 28.195 |
| 01:33 ET | 8209 | 28.205 |
| 01:35 ET | 2314 | 28.225 |
| 01:37 ET | 1415 | 28.2 |
| 01:39 ET | 1667 | 28.195 |
| 01:42 ET | 1795 | 28.2 |
| 01:44 ET | 2110 | 28.215 |
| 01:46 ET | 1576 | 28.215 |
| 01:48 ET | 1690 | 28.235 |
| 01:50 ET | 462 | 28.235 |
| 01:51 ET | 3543 | 28.235 |
| 01:53 ET | 4507 | 28.225 |
| 01:55 ET | 468 | 28.23 |
| 01:57 ET | 3883 | 28.25 |
| 02:00 ET | 2186 | 28.235 |
| 02:02 ET | 2136 | 28.225 |
| 02:04 ET | 713 | 28.235 |
| 02:06 ET | 442 | 28.235 |
| 02:08 ET | 3182 | 28.24 |
| 02:09 ET | 300 | 28.245 |
| 02:11 ET | 1584 | 28.235 |
| 02:13 ET | 276 | 28.235 |
Sep 20, 2024
DJ S&P 500 Futures Decline In Premarket Trading; FedEx, Frontline Lag, from 7:30AM ET on Friday Sep 20, 2024 by Dow Jones
7:30AM ET on Friday Sep 20, 2024 by Dow Jones
Sep 18, 2024
DJ S&P 500 Futures Up In Premarket Trading; Manhattan Associates, Casella Waste Sys Lag, from 7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
7:30AM ET on Wednesday Sep 18, 2024 by Dow Jones
Sep 3, 2024
Press Release: Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
5:14PM ET on Tuesday Sep 03, 2024 by Dow JonesRoyalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement, from 5:14PM ET on Tuesday Sep 03, 2024 by Dow Jones
5:14PM ET on Tuesday Sep 03, 2024 by Dow JonesPress Release: Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement, from 5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones
5:06PM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.8B | 18.8x | +1.83% |
Amneal Pharmaceuticals Inc | 2.6B | -14.1x | --- |
Endo Inc | 1.9B | 0.4x | --- |
Catalent Inc | 11.0B | -10.5x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 19.0x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Head of Human Capital
- Molly Sawaya
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.8B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 593.5M |
Dividend Yield | 2.98% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 09-13-24 |
Beta | 0.46 |
EPS | $1.50 |
Book Value | $14.61 |
P/E Ratio | 18.8x |
Price/Sales (TTM) | 7.5 |
Price/Cash Flow (TTM) | 20.0x |
Operating Margin | 42.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
